In this paper, we develop a model for the evolution of the Multiple Sclerosis pathology that considers the modulatory influence of cytokines on the activation rate of macrophages. Our starting point is the reaction–diffusion-chemotaxis model proposed in 4, and we modify the macrophage activation mechanism. What triggers the immune cells into an active state is still debated in the medical literature. In this paper, we explore the hypothesis, e.g., Lassmann, (2018), that cytokines mediate the activation mechanism. Our primary focus is on the rigorous analysis of instabilities responsible for the formation of demyelinating lesions and on the qualitative properties of the solution. Through a weakly nonlinear analysis, we characterize the chemotaxis-driven Turing instability and construct the stationary patterns that emerge from this instability. Using biologically relevant parameter values, we show that the asymptotic solutions of our model system reproduce the concentric demyelinating rings, confluent plaques, and preactive lesions observed in Balò sclerosis and type III Multiple Sclerosis. Furthermore, we explore the initiation and progression of demyelinated plaques through extensive numerical simulations on two-dimensional domains. Our findings reveal that the alternative scenario proposed here results in a less aggressive pathology characterized by reduced inflammation levels and significantly slower disease progression. Under the appropriate regularity conditions on the initial data, we prove the existence of a unique global solution to our proposed system. This study provides insights into the role of cytokines in the pathogenesis of Multiple Sclerosis, shedding light on the disease's dynamics and offering potential avenues for therapeutic interventions. • We formulate an MS model considering cytokines' role in macrophage activation. • We study the Turing bifurcation and pattern formation. • The model replicates pathological scenarios observed in patients. • Cytokine-mediated activation results in a less aggressive and slower pathology. • We prove the existence of a unique regular global solution. [ABSTRACT FROM AUTHOR]